Literature DB >> 22728286

Altered serum pro-inflammatory cytokines in children with Down's syndrome.

Mahmoud Nateghi Rostami1, Masoumeh Douraghi, Akram Miramin Mohammadi, Bahram Nikmanesh.   

Abstract

There are reports showing that pro-inflammatory cytokines are dysregulated in patients with Down's syndrome (DS). However, most of these reports concern adults. We analyzed cytokine levels in serum samples from children with DS, and compared them with samples from intellectually disabled (ID), and healthy, control children. Blood samples were collected from 24 DS, 24 age-/sex-matched ID, and 24 age-/sex-matched healthy, control children. Serum levels of the cytokines IL-5, IL-10, IL-13, IFN-γ, and TNF-α were measured using a sandwich ELISA method, . The age range of the children was 1-15 years, with a mean ± SD of 5.75 ± 4.36 years. TNF-α levels were significantly higher in the DS and ID groups compared with those found in healthy, control children (P<0.05). The DS and ID groups had significantly higher IFN-γ levels compared with healthy, control children (P = 0.0002 and P<0.01, respectively), with significant higher levels in the DS than the ID group (P<0.05). Serum from the ID group showed significantly higher IL-10 levels compared with those from the DS group (P<0.05), but not the healthy, control group. Significant correlations were found between the differences in TNF-α and IFN-γ levels, in both ID (rs = 0.558; P = 0.005) and DS children (rs = 0.405; P<0.05). There were no significant differences found in serum levels of IL-13 between the groups, and IL-5 was not detectable in any of the serum samples. Levels of TNF-α and IFN-γ were increased, and IL-10 decreased in serum from children with DS. It may be that these differences contribute to the clinical symptoms seen in DS: consequently, these pro-inflammatory cytokines might be useful as early biomarkers of the disorders associated with DS.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22728286     DOI: 10.1684/ecn.2012.0307

Source DB:  PubMed          Journal:  Eur Cytokine Netw        ISSN: 1148-5493            Impact factor:   2.737


  20 in total

1.  Apigenin as a Candidate Prenatal Treatment for Trisomy 21: Effects in Human Amniocytes and the Ts1Cje Mouse Model.

Authors:  Faycal Guedj; Ashley E Siegel; Jeroen L A Pennings; Fatimah Alsebaa; Lauren J Massingham; Umadevi Tantravahi; Diana W Bianchi
Journal:  Am J Hum Genet       Date:  2020-10-23       Impact factor: 11.025

2.  Comparison of salivary cytokines levels among individuals with Down syndrome, cerebral palsy and normoactive.

Authors:  Carolina-Hartung Habibe; Rosemeire-Arai Yoshida; Renata Gorjão; Gabriela-Mancia de Gutierrez; Debora Heller; Alexander Birbrair; Maria-Teresa-Botti-Rodrigues Santos
Journal:  J Clin Exp Dent       Date:  2020-05-01

Review 3.  Prevention and Periodontal Treatment in Down Syndrome Patients: A Systematic Review.

Authors:  Rafael Ferreira; Raphaella Coelho Michel; Sebastião Luiz Aguiar Greghi; Maria Lúcia Rubo de Resende; Adriana Campos Passanezi Sant'Ana; Carla Andreotti Damante; Mariana Schutzer Ragghianti Zangrando
Journal:  PLoS One       Date:  2016-06-29       Impact factor: 3.240

4.  Trisomy 21 causes changes in the circulating proteome indicative of chronic autoinflammation.

Authors:  Kelly D Sullivan; Donald Evans; Ahwan Pandey; Thomas H Hraha; Keith P Smith; Neil Markham; Angela L Rachubinski; Kristine Wolter-Warmerdam; Francis Hickey; Joaquin M Espinosa; Thomas Blumenthal
Journal:  Sci Rep       Date:  2017-11-01       Impact factor: 4.379

5.  Aberrations in circulating inflammatory cytokine levels in patients with Down syndrome: a meta-analysis.

Authors:  Yan Zhang; Meng Che; Jing Yuan; Yun Yu; Chang Cao; Xiao-Yan Qin; Yong Cheng
Journal:  Oncotarget       Date:  2017-09-19

6.  Altered endotoxin responsiveness in healthy children with Down syndrome.

Authors:  Dean Huggard; Fiona McGrane; Niamh Lagan; Edna Roche; Joanne Balfe; Timothy Ronan Leahy; Orla Franklin; Ana Moreno; Ashanty M Melo; Derek G Doherty; Eleanor J Molloy
Journal:  BMC Immunol       Date:  2018-11-03       Impact factor: 3.615

7.  Genetic Susceptibility to Periodontal Disease in Down Syndrome: A Case-Control Study.

Authors:  María Fernández; Alicia de Coo; Inés Quintela; Eliane García; Márcio Diniz-Freitas; Jacobo Limeres; Pedro Diz; Juan Blanco; Ángel Carracedo; Raquel Cruz
Journal:  Int J Mol Sci       Date:  2021-06-10       Impact factor: 5.923

8.  Absence of IFNγ promotes hippocampal plasticity and enhances cognitive performance.

Authors:  S Monteiro; F M Ferreira; V Pinto; S Roque; M Morais; D de Sá-Calçada; C Mota; M Correia-Neves; J J Cerqueira
Journal:  Transl Psychiatry       Date:  2016-01-05       Impact factor: 6.222

Review 9.  Non-IgE-Mediated Gastrointestinal Food Allergies in Children: An Update.

Authors:  Roxane Labrosse; François Graham; Jean-Christoph Caubet
Journal:  Nutrients       Date:  2020-07-14       Impact factor: 5.717

10.  Interleukin 6 and 10 Serum Levels and Genetic Polymorphisms in Children with Down Syndrome.

Authors:  Marlon Fraga Mattos; Patrícia Matos Biselli-Chicote; Joice Matos Biselli; Thiago Luís da Silva Assembleia; Eny Maria Goloni-Bertollo; Érika Cristina Pavarino
Journal:  Mediators Inflamm       Date:  2018-08-16       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.